Two Drugmakers Dominate Obesity Boom, Tiny Fund Holds Both
Two drugmakers lead the obesity drug surge, while a small fund owns both names at a fractional stake. This highlights...
Starting your investment journey? Learn what to watch out for as a new investor to avoid common pitfalls and make wise choices.
27,695 articlesTwo drugmakers lead the obesity drug surge, while a small fund owns both names at a fractional stake. This highlights...
As the Iran conflict intensified in early 2026, gold failed to rally as expected. A hypothetical $10,000 in gold woul...
A fresh Federal Reserve briefing shows a modest emergency cushion among households, but retirement readiness remains ...
Public life aside, money stress nearly derailed a famous romance. This insight shows how a tense breakup can reveal t...
Coinbase posted $1.35 billion in stablecoin revenue for 2025, with analysts signaling a sevenfold rise as stablecoins...
Markets shift from mega-cap tech to overlooked small firms. This story highlights three small-cap ETFs to buy before ...
Palantir rides the AI hype as demand grows, but valuation concerns and fears of the AI gold rush eroding its edge kee...
With burnout on the rise in early 2026, workers seek structured ways to reduce load without leaving their jobs. Inves...
Oil prices surged as tensions with Iran intensified, signaling higher pump costs for consumers. Analysts warn househo...
Former President Trump floated easing oil sanctions and hinted the Iran conflict could wrap up soon, sending ripples ...
Ethereum rose above 2,000 while a scarcity signal on Binance turned positive, suggesting thinner sell-side liquidity....
Traders eye a clearer long-run path for algorand as the network scales DeFi apps and CBDC pilots. This report outline...